Friday, November 15, 2024
HomeChildren's HealthINTEGRA Biosciences’ pipettes assist to fight prostate most cancers

INTEGRA Biosciences’ pipettes assist to fight prostate most cancers



LynxDx, a Michigan diagnostics laboratory specializing in prostate most cancers screening and danger prediction, acquired liquid dealing with options from INTEGRA Biosciences to streamline its pattern preparation for top throughput COVID-19 testing.

The lab is now within the means of shifting these merchandise over to prostate most cancers screening, the place they’re serving to to enhance consequence accuracy and turnaround occasions and, in the end, help well timed analysis and therapy. LynxDx performs prostate most cancers screening utilizing its proprietary MyProstateScore 2.0 (MPS2) strategy, a non-invasive urine check that detects the presence of 18 genetic biomarkers linked to prostate most cancers. MPS2 makes use of a cohort-specific algorithm to optimize diagnostic accuracy and supply scientific flexibility for biopsy naïve sufferers and sufferers with a previous destructive biopsy, offering extremely correct and particular insights that may scale back the frequency of pointless and probably high-risk biopsies.

In early 2020, LynxDx adopted 4 VIAFLO 96 handheld digital pipettes and 4 VOYAGER adjustable tip spacing pipettes from INTEGRA to permit it to rapidly transition over to high-volume COVID-19 testing. Dr. Jacob Meyers, Senior Scientist of Analysis and Growth at LynxDx, defined: “We selected INTEGRA’s VIAFLO 96 and VOYAGER pipettes as a result of we wanted strong and dependable techniques that may permit us to constantly deal with giant numbers of extremely variable saliva samples for correct and fast outcomes. These versatile merchandise performed a key function in enabling us to keep up brief turnaround occasions for COVID-19 testing, in addition to to handle an elevated workload as our most cancers screening operations have progressively received again on observe over the current months.”

We’re already utilizing the VOYAGER pipettes in our most cancers screening workflow, and we’re at present performing validation of the VIAFLO 96 pipettes for this software. We’d additionally like to accumulate further INTEGRA merchandise within the close to future, as these pipetting options will permit us to additional streamline and automate our liquid dealing with workflows in preparation for the diagnostic wants of the longer term,” Jacob concluded.

Go to the INTEGRA Biosciences web site to be taught extra.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments